Transitioning from Academia to Biotech — Yes, another oneWhen our darling global pandemic struck, I had been a Postdoctoral Research Associate at University College London for over 2 years. At…Sep 30, 2021Sep 30, 2021
Ochre Bio Leadership Series — Eduardo Martins on NASH Clinical DevelopmentLast year, Ochre Bio sat down (virtually) with Eduardo Martins, (who is now the CMO at Sagimet Biosciences), to discuss the challenges of…Jun 28, 2021Jun 28, 2021
Introducing Ochre Bio2020 will be remembered as the year of RNA blockbusters, including both COVID-19 vaccines and Novartis’ Leqvio. While the traditional view…Jun 13, 2021Jun 13, 2021
